Sampre Nutritions Ltd Falls to 52-Week Low of Rs 6.82 as Sell-Off Deepens

Price Action and Market Context

The recent price slide for Sampre Nutritions Ltd stands in stark contrast to the broader market environment. While the Sensex opened higher at 78,461.16 and has gained 0.22% today, supported by mega-cap stocks, Sampre Nutritions Ltd continues to trade below all key moving averages — including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This technical positioning signals sustained downward momentum. The stock’s 52-week high of Rs 42.33, reached within the last year, highlights the severity of the current decline, representing an approximate 84% drop from peak levels. What is driving such persistent weakness in Sampre Nutritions Ltd when the broader market is in rally mode?

Financial Performance: A Tale of Contrasts

Despite the share price weakness, the company’s recent financial results offer a more nuanced picture. Sampre Nutritions Ltd reported a remarkable 117.74% increase in net profit for the latest period ending March 2026, with net sales for the last six months rising 68.46% to Rs 22.49 crores. The profit after tax (PAT) for the same period stood at Rs 1.97 crores, reflecting a significant improvement. Additionally, the company has declared positive results for four consecutive quarters, suggesting some operational resilience. The debtors turnover ratio at 3.27 times is the highest recorded, indicating improved efficiency in receivables management. Could these financial gains signal an underlying recovery despite the share price slump?

Valuation and Capital Efficiency

The valuation metrics for Sampre Nutritions Ltd present a complex picture. The company’s return on capital employed (ROCE) remains modest at 2.6%, which is low but represents an improvement over the long-term average of 1.28%. The enterprise value to capital employed ratio stands at a very attractive 0.7, suggesting the stock is trading at a discount relative to its capital base. However, the company’s ability to service debt remains a concern, with an average EBIT to interest coverage ratio of just 0.47, indicating limited cushion against interest obligations. The price-to-earnings multiple is not meaningful due to loss-making periods, but the PEG ratio of 0.1 reflects the disconnect between earnings growth and share price performance. With the stock at its weakest in 52 weeks, should you be buying the dip on Sampre Nutritions Ltd or does the data suggest staying on the sidelines?

Long-Term Growth and Quality Metrics

Over the past five years, Sampre Nutritions Ltd has experienced an annual operating profit growth rate of 18.30%, which is moderate but not robust enough to inspire strong confidence. The company’s average return on capital employed of 1.28% over the long term points to weak capital efficiency. Furthermore, the stock has underperformed the BSE500 index over the last three years, one year, and three months, with a one-year return of -26.30% compared to the Sensex’s -5.97%. Institutional ownership remains low, with majority shareholders being non-institutional, which may reflect limited confidence from large investors. How do these quality metrics influence the outlook for Sampre Nutritions Ltd at current levels?

Technical Indicators Confirm Bearish Momentum

The technical landscape for Sampre Nutritions Ltd remains predominantly negative. Weekly and monthly MACD readings are bearish, as are Bollinger Bands on both timeframes. The daily moving averages also signal a bearish trend, with the stock trading below all key averages. The KST indicator shows a mixed picture with weekly readings bearish but monthly readings bullish, while Dow Theory assessments are mildly bearish on both weekly and monthly scales. The absence of a clear RSI signal suggests limited momentum shifts at present. This technical profile aligns with the recent price weakness and suggests continued pressure in the near term. Is the current technical setup indicative of further downside or a potential base formation?

Summary and Investor Considerations

The data points to continued pressure on Sampre Nutritions Ltd shares, with the stock hitting a new 52-week low amid a broader market rally. While recent quarterly numbers offer a contrasting data point with strong profit growth and improving sales, the company’s long-term fundamentals remain subdued, with weak capital returns and limited debt servicing capacity. The technical indicators reinforce the bearish sentiment, and the stock’s valuation metrics, though attractive on some fronts, reflect the market’s cautious stance. Buy, sell, or hold at a 52-week low? The complete multi-factor analysis of Sampre Nutritions Ltd weighs all these signals.

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →